Scientist

Scott Rocklage is an executive in the healthcare industry. For over three decades he has served as a board member and top executive for a number of pharmaceutical companies.

As an executive of these various companies, he has helped provide them with the leadership necessary to become and remain as top companies in the industry. As of today, his most notable position is as the Managing Partner of the company known as 5AM Ventures.

As the managing partner, Rocklage has been able to provide direction for the company that has enabled it to become one of the top companies in its respective industry. What sets Scott apart from other executives is his expertise and experience. For over three decades, he has helped numerous companies attain a number of important goals.

Before Scott became the managing partner at 5AM Ventures, he held a number of other positions at other companies. One of these positions was as the Chairman and Chief Executive Officer of a company known as Cubist Pharmaceuticals.

At this position, he provided important leadership as well as expertise to help this company become a successful firm in the pharmaceutical industry. Another position that Scott held was as the President and CEO of Nycomed Salutar. Read more: Scott Racklage | Bloomberg and Scott Racklage | Crunchbase

While Scott is the current managing partner of 5AM Ventures, he also holds other positions with other companies. He is the Board Chairman of Rennovia, Kinestral and Cidara. Rocklage is also on the Board of the company known as Epirus.

Scott held other previous positions such as Executive Chairman of Ilypsa, Miklana and Semprus. Before Scott became a healthcare company executive, he first received his education. Rocklage attended the University of California Berkeley where he completed a bachelor’s degree in Chemistry.

After finishing this degree program, he would then complete a doctorate degree in Chemistry at the Massachusetts Institute of Technology.